CAPZA2 and cancer: In this context, Ohishi et al. affirmed that TAB182 regulates the invasion of pancreatic malignant cells by binding to the actin-capping protein CapZA2 and enhancing its’ interaction with the cytoskeleton [28], suggesting that TAB182 may act differently in different types of cancer cells.